Itamar Raz

1.2k total citations
16 papers, 359 citations indexed

About

Itamar Raz is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Itamar Raz has authored 16 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Itamar Raz's work include Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cardiovascular Function and Risk Factors (2 papers). Itamar Raz is often cited by papers focused on Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cardiovascular Function and Risk Factors (2 papers). Itamar Raz collaborates with scholars based in Israel, United States and Sweden. Itamar Raz's co-authors include Avivit Cahn, Simona Cernea, Ofri Mosenzon, Deepak L. Bhatt, Benjamin M. Scirica, Eugene Braunwald, Darren K. McGuire, Lawrence A. Leiter, Yared Gurmu and Estella Kanevsky and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Itamar Raz

14 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itamar Raz Israel 8 252 110 110 97 43 16 359
Shigeto Kanada Japan 9 188 0.7× 114 1.0× 96 0.9× 77 0.8× 34 0.8× 9 339
Taro Okamoto Japan 12 215 0.9× 143 1.3× 121 1.1× 31 0.3× 60 1.4× 32 438
Xiaoxuan Ma China 3 212 0.8× 103 0.9× 104 0.9× 62 0.6× 11 0.3× 5 305
Yifei Chen China 10 305 1.2× 109 1.0× 151 1.4× 43 0.4× 23 0.5× 32 468
Ajeeth K. Pingili United States 13 97 0.4× 51 0.5× 107 1.0× 81 0.8× 89 2.1× 18 348
Annelie Blumrich Germany 8 230 0.9× 80 0.7× 160 1.5× 128 1.3× 24 0.6× 9 408
Ivano Franzetti Italy 14 430 1.7× 177 1.6× 212 1.9× 121 1.2× 42 1.0× 21 604
Miriam Kozárová Slovakia 9 179 0.7× 156 1.4× 120 1.1× 33 0.3× 18 0.4× 25 274
Knut Robert Andersen Germany 5 344 1.4× 162 1.5× 175 1.6× 36 0.4× 15 0.3× 5 374
Monia Garofolo Italy 12 197 0.8× 54 0.5× 79 0.7× 49 0.5× 17 0.4× 28 373

Countries citing papers authored by Itamar Raz

Since Specialization
Citations

This map shows the geographic impact of Itamar Raz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itamar Raz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itamar Raz more than expected).

Fields of papers citing papers by Itamar Raz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itamar Raz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itamar Raz. The network helps show where Itamar Raz may publish in the future.

Co-authorship network of co-authors of Itamar Raz

This figure shows the co-authorship network connecting the top 25 collaborators of Itamar Raz. A scholar is included among the top collaborators of Itamar Raz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itamar Raz. Itamar Raz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Haller, Paul M., Erica L. Goodrich, Stephen Wiviott, et al.. (2025). GALECTIN-3 AND CARDIOVASCULAR AND KIDNEY OUTCOMES: INDIVIDUAL PATIENT DATA METAANALYSIS OF 74,358 PATIENTS FROM 5 MULTINATIONAL CLINICAL TRIALS. Journal of the American College of Cardiology. 85(12). 1786–1786. 1 indexed citations
2.
Raz, Itamar, Michael H. Brodsky, Nili Stein, et al.. (2024). Nontuberculous Mycobacterial Infection and Pulmonary Disease in Northern Israel. CHEST Journal. 167(6). 1547–1556.
3.
Cahn, Avivit, Stephen D. Wiviott, Ofri Mosenzon, et al.. (2022). Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58. Diabetes Care. 45(4). 938–946. 26 indexed citations
4.
Berg, David D., Stephen D. Wiviott, Benjamin M. Scirica, et al.. (2021). A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes. Diabetes Care. 44(11). 2573–2581. 17 indexed citations
5.
Bonaca, Marc P., Stephen D. Wiviott, Thomas A. Zelniker, et al.. (2020). Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58. Circulation. 142(8). 734–747. 46 indexed citations
6.
Bergmark, Brian A., Deepak L. Bhatt, Darren K. McGuire, et al.. (2019). Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction. Circulation. 140(12). 1004–1014. 66 indexed citations
7.
Cahn, Avivit, Simona Cernea, & Itamar Raz. (2016). An update on DPP-4 inhibitors in the management of type 2 diabetes. Expert Opinion on Emerging Drugs. 21(4). 409–419. 59 indexed citations
8.
Leiter, Lawrence A., Hwee Teoh, Eugene Braunwald, et al.. (2015). Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial. Diabetes Care. 38(6). 1145–1153. 74 indexed citations
9.
Prato, Stefano Del & Itamar Raz. (2013). Introduction to the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy). Diabetes Care. 36(Supplement_2). S111–S112. 1 indexed citations
10.
Mosenzon, Ofri & Itamar Raz. (2012). Potential cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: current evidence and ongoing trials. European Heart Journal Supplements. 14(suppl B). B22–B29. 4 indexed citations
11.
Schroeder, Josh E., et al.. (2011). Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews. 28(1). 71–75. 26 indexed citations
12.
13.
Khamaisi, Mogher & Itamar Raz. (2008). Endothelial Dysfunction in Diabetes: The Role of Protein Kinase C. Vascular Disease Prevention. 3(1). 305–312.
14.
Mosseri, Morris, Menachem Nahir, Yoseph Rozenman, et al.. (1998). Diffuse Narrowing of Coronary Arteries in Diabetic Patients: The Earliest Phase of Coronary Artery Disease. Cardiology. 89(2). 103–110. 27 indexed citations
15.
Harats, Dror, et al.. (1990). Ultrasonographic appearance of well-defined splenic space-occupying lesions in Gaucher's disease.. PubMed. 26(3). 168–70. 1 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeto Kanada Breakdown of academic impact, for papers by Taro Okamoto Breakdown of academic impact, for papers by Xiaoxuan Ma Breakdown of academic impact, for papers by Yifei Chen Breakdown of academic impact, for papers by Ajeeth K. Pingili Breakdown of academic impact, for papers by Annelie Blumrich Breakdown of academic impact, for papers by Ivano Franzetti Breakdown of academic impact, for papers by Miriam Kozárová Breakdown of academic impact, for papers by Knut Robert Andersen Breakdown of academic impact, for papers by Monia Garofolo
Rankless by CCL
2026